The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5
Open accessAbstract
Double-stranded RNAs ≈21 nucleotides long [small interfering RNA (siRNA)] are recognized as powerful reagents to reduce the expression of specific genes. To use them as reagents to protect cells against viral infection, effective methods for introducing siRNAs into primary cells are required. Here, we describe success in constructing a lentivirus-based vector to introduce siRNAs against the HIV-1 coreceptor, CCR5, into human peripheral blood T lymphocytes. With high-titer vector stocks, >40% of the peripheral blood T lymphocytes could be transduced, and the expression of a potent CCR5-siRNA resulted in up to 10-fold inhibition of CCR5 expression on the cell surface over a period of 2 weeks in the absence of selection. In contrast, the expression of another major HIV-1 coreceptor, CXCR4, was not affected. Importantly, blocking CCR5 expression by siRNAs provided a substantial protection for the lymphocyte populations from CCR5-tropic HIV-1 virus infection, dropping infected cells by 3- to 7-fold; only a minimal effect on infection by a CXCR4-tropic virus was observed. Thus, our studies demonstrate the feasibility and potential of lentiviral vector-mediated delivery of siRNAs as a general means of intracellular immunization for the treatment of HIV-1 and other viral diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,999
Self-citationShort hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., et al. (1996) · Nature Medicine · doi:10.1038/nm1196-1240 · Cited by 1,358
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., & Ho, D. D. (1993) · Science · doi:10.1126/science.8356453 · Cited by 1,249
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., & Mackay, C. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1925 · Cited by 1,134
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells
Sui, G., Soohoo, C., Affar, E. B., Gay, F., Shi, Y., Forrester, W. C., & Shi, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117599 · Cited by 1,104
RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells
Yu, J.-Y., DeRuiter, S. L., & Turner, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092143499 · Cited by 1,039
Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., de Goede, R. E., van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F., & Tersmette, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1354-1360.1992 · Cited by 1,032
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 975
Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells
Lee, N. S., Dohjima, T., Bauer, G., Li, H., Li, M.-J., Ehsani, A., Salvaterra, P., & Rossi, J. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-500 · Cited by 953
Effective expression of small interfering RNA in human cells
Paul, C. P., Good, P. D., Winer, I., & Engelke, D. R. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-505 · Cited by 820
siRNA-directed inhibition of HIV-1 infection
Novina, C. D., Murray, M. F., Dykxhoorn, D. M., Beresford, P. J., Riess, J., Lee, S.-K., Collman, R. G., Lieberman, J., Shankar, P., & Sharp, P. A. (2002) · Nature Medicine · doi:10.1038/nm725 · Cited by 773
Modulation of HIV-1 replication by RNA interference
Jacque, J.-M., Triques, K., & Stevenson, M. (2002) · Nature · doi:10.1038/nature00896 · Cited by 719
Miyagishi, M., & Taira, K. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-497 · Cited by 710
Sharp, P. A. (2001) · Genes & Development · doi:10.1101/gad.880001 · Cited by 701
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
SURVEY AND SUMMARY Transcription by RNA polymerases I and III
Paule, M. R. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1283 · Cited by 502
Chapter 5 Generation of High-Titer Pseudotyped Retroviral Vectors with Very Broad Host Range
Yee, J.-K., Friedmann, T., & Burns, J. C. (1994) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60600-7 · Cited by 448
The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
Michael, N. L., Chang, G., Loum, L. G., Mascola, J. R., Dondero, D., Birx, D. L., & Sheppard, H. W. (1997) · Nature Medicine · doi:10.1038/nm0397-338 · Cited by 448
Baltimore, D. (1988) · Nature · doi:10.1038/335395a0 · Cited by 420
Self-citationZimmerman, P. A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401665 · Cited by 416
Coburn, G. A., & Cullen, B. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9225-9231.2002 · Cited by 413
Richman, D. D., & Bozzette, S. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.968 · Cited by 401
Expanding small RNA interference
Tuschl, T. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-446 · Cited by 395
Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32
Benkirane, M., Jin, D.-Y., Chun, R. F., Koup, R. A., & Jeang, K.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30603 · Cited by 377
Ancient Pathways Programmed by Small RNAs
Zamore, P. D. (2002) · Science · doi:10.1126/science.1072457 · Cited by 360
HIV-1 infection in an individual homozygous for the CCR5 deletion allele
Biti, R., Ffrench, R., Young, J., Bennetts, B., Stewart, G., & Liang, T. (1997) · Nature Medicine · doi:10.1038/nm0397-252 · Cited by 352
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
Stewart, S. A., Poon, B., Jowett, J. B., & Chen, I. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5579-5592.1997 · Cited by 350
Self-citationHIV entry and tropism: the chemokine receptor connection.
Berger, E. A. (1997) · PubMed · Cited by 313
Chackerian, B., Long, E. M., Luciw, P. A., & Overbaugh, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3932-3939.1997 · Cited by 267
Viral Phenotype and Immune Response in Primary Human Immunodeficiency Virus Type 1 Infection
Roos, M. T. L., Lange, J. M. A., de Goede, R. E. Y., Coutinho, R. A., Schellekens, P. T. A., Miedema, F., & Tersmette, M. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.3.427 · Cited by 266
O'Brien, S. J., & Moore, J. P. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17710.x · Cited by 254
HIV-1 infection in an individual homozygous for CCR5▵32
Theodorou, L., Meyer, L., Magierowska, M., Katlama, C., & Rouzioux, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62411-7 · Cited by 240
Inhibition of Retroviral Pathogenesis by RNA Interference
Hu, W.-Y., Myers, C. P., Kilzer, J. M., Pfaff, S. L., & Bushman, F. D. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00975-2 · Cited by 181
The University of North Carolina at Chapel Hill University Libraries (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/81xb-we92 · Cited by 180
Homozygous Δ32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
Balotta, C., Bagnarelli, P., Violin, M., Ridolfo, A. L., Zhou, D., Berlusconi, A., Corvasce, S., Corbellino, M., Clementi, M., Clerici, M., et al. (1997) · AIDS · doi:10.1097/00002030-199710000-00001 · Cited by 123
Co‐receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands
Simmons, G., Reeves, J. D., Hibbitts, S. J., Stine, J. T., Gray, P. W., Proudfoot, A. E. I., & Clapham, P. R. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17719.x · Cited by 123
Steinberger, P., Andris‐Widhopf, J., Bühler, B., Torbett, B. E., & Barbas, C. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.805 · Cited by 114
An, D. S., Wersto, R. P., Agricola, B. A., Metzger, M. E., Lu, S. Y., Amado, R. G., Chen, I. S. Y., & Donahue, R. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1286-1295.2000 · Cited by 114
Self-citationNaldini, L., & Verma, I. M. (2000) · Advances in virus research · doi:10.1016/s0065-3527(00)55020-9 · Cited by 108
Yang, A., Bai, X., Huang, X. F., Yao, C., & Chen, S. Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11567 · Cited by 106
Frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C
Woitas, R. P., Ahlenstiel, G., Iwan, A., Rockstroh, J. K., Brackmann, H. H., Kupfer, B., Matz, B., Offergeld, R., Sauerbruch, T., & Spengler, U. (2002) · Gastroenterology · doi:10.1053/gast.2002.33660 · Cited by 104
In Vivo Pathogenesis of a Human Immunodeficiency Virus Type 1 Reporter Virus
Jamieson, B. D., & Zack, J. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6520-6526.1998 · Cited by 86
Kitami, T., & Nadeau, J. H. (2002) · Nature Genetics · doi:10.1038/ng1202-681a · Cited by 79
An, D. S., Kung, S. K. P., Bonifacino, A. C., Wersto, R. P., Metzger, M. E., Agricola, B. A., Mao, S. H., Chen, I. S. Y., & Donahue, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3547-3555.2001 · Cited by 71
Self-citationSchroers, R., Davis, C., Wagner, H.-J., & Chen, S.-Y. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301711 · Cited by 46
Medical cardiovascular treatment trials: Relevant to medical ophthalmology in 1997?
Dodson, P. M., & Kritzinger, E. E. (1997) · Eye · doi:10.1038/eye.1997.2 · Cited by 23
Cited by
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Killing the messenger: short RNAs that silence gene expression
Dykxhoorn, D. M., Novina, C. D., & Sharp, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1129 · Cited by 1,182
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,064
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1410 · Cited by 999
Revealing the world of RNA interference
Mello, C. C., & Conte, D. (2004) · Nature · doi:10.1038/nature02872 · Cited by 997
Metadata
- Authors
- Qin, X.-F., An, D. S., Chen, I. S. Y., & Baltimore, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-12-23
- Volume
- 100
- Issue
- 1
- Pages
- 183-188
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2135135539
- Cited by
- 701
- References
- 60
- FWCI
- 31.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.